Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT06121297

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

Conditions: Systemic Lupus Erythematosus, Lupus Nephritis

Sex: All
Ages: 12 Years – 65 Years
Healthy volunteers: No
Phase: PHASE1, PHASE2
Enrollment: 28
Sponsor: Cabaletta Bio

Location: University of California Irvine Orange California

Summary

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

Eligibility Criteria

Inclusion Criteria: * Age ≥18 and ≤65 (Adults) or Age ≥12 to \

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT06121297). StuddyBuddy aggregates publicly available trial information.